Study Summary
The purpose of this study is to evaluate the safety and efficacy of IFN-α combined with CAR-T cell therapy in relapsed and refractory acute lymphoblastic leukemia (R/R ALL).
Want to learn more about this trial?
Request More InfoInterventions
IFN-α combined with CAR-T cell therapyCOMBINATION_PRODUCT
Adults: 14 daily intramuscular injections 300 million IU of Interferon-α for a 28-day cycle.
Children: 14 daily intramuscular injections 200mg/m\^2 of Interferon-α for a 28-day cycle.
CAR T cell: (1-2)×10\^7/kg, intravenously infusion.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou | Jiangsu | China |